Geode Capital Management, LLC Spectrum Pharmaceuticals Inc Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.65 - $1.31 $17,071 - $34,405	26,264 Added 1.49%	1,783,701 $1.71 Million
Q1 2023 May 15, 2023	BUY	$0.38 - $1.07 $93,189 - $262,401	245,235 Added 16.22%	1,757,437 $1.32 Million
Q4 2022 Feb 13, 2023	SELL	$0.32 - $0.52 $12,656 - $20,566	-39,550 Reduced 2.55%	1,512,202 $557,000
Q3 2022 Nov 14, 2022	SELL	$0.43 - $1.56 $79,108 - $286,997	-183,973 Reduced 10.6%	1,551,752 $667,000
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.4 $694,264 - $1.39 Million	-991,807 Reduced 36.36%	1,735,725 $1.35 Million
Q1 2022 May 13, 2022	BUY	$0.63 - $1.59 $128,455 - $324,196	203,897 Added 8.08%	2,727,532 $3.52 Million
Q4 2021 Feb 11, 2022	SELL	$1.27 - $2.42 $206,880 - $394,213	-162,898 Reduced 6.06%	2,523,635 $3.21 Million
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.82 $84,426 - $150,003	39,268 Added 1.48%	2,686,533 $5.86 Million
Q2 2021 Aug 13, 2021	BUY	$2.89 - $4.45 $705,220 - $1.09 Million	244,021 Added 10.15%	2,647,265 $9.93 Million
Q1 2021 May 12, 2021	BUY	$2.9 - $4.09 $627,977 - $885,664	216,544 Added 9.9%	2,403,244 $7.83 Million
Q4 2020 Feb 12, 2021	BUY	$3.38 - $5.14 $707,630 - $1.08 Million	209,358 Added 10.59%	2,186,700 $7.46 Million
Q3 2020 Nov 13, 2020	BUY	$2.99 - $4.9 $918,623 - $1.51 Million	307,232 Added 18.4%	1,977,342 $8.07 Million
Q2 2020 Aug 13, 2020	BUY	$2.11 - $3.38 $147,771 - $236,714	70,034 Added 4.38%	1,670,110 $5.64 Million
Q1 2020 May 14, 2020	BUY	$1.83 - $3.45 $107,327 - $202,339	58,649 Added 3.8%	1,600,076 $3.73 Million
Q4 2019 Feb 13, 2020	BUY	$3.5 - $10.35 $246,904 - $730,130	70,544 Added 4.8%	1,541,427 $5.61 Million
Q3 2019 Nov 12, 2019	BUY	$7.03 - $9.7 $402,889 - $555,907	57,310 Added 4.05%	1,470,883 $12.2 Million
Q2 2019 Aug 14, 2019	BUY	$7.36 - $11.26 $1 Million - $1.53 Million	136,312 Added 10.67%	1,413,573 $12.2 Million
Q1 2019 May 14, 2019	BUY	$9.08 - $11.84 $1.1 Million - $1.43 Million	121,142 Added 10.48%	1,277,261 $13.7 Million
Q4 2018 Feb 13, 2019	BUY	$6.39 - $16.99 $835,268 - $2.22 Million	130,715 Added 12.75%	1,156,119 $10.1 Million
Q3 2018 Nov 13, 2018	BUY	$16.52 - $24.82 $939,459 - $1.41 Million	56,868 Added 5.87%	1,025,404 $17.2 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $2 Million - $3.04 Million	139,893 Added 16.88%	968,536 $20.3 Million
Q1 2018 May 15, 2018	BUY	$16.09 - $23.07 $270,247 - $387,483	16,796 Added 2.07%	828,643 $13.3 Million
Q4 2017 Feb 13, 2018	BUY	$13.36 - $20.73 $2.1 Million - $3.26 Million	157,130 Added 24.0%	811,847 $15.4 Million
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $500,150 - $804,241	57,160 Added 9.57%	654,717 $9.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	597,557	597,557 $4.45 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account